JPH09501418A - エアゾル化タンパク質の安定化 - Google Patents

エアゾル化タンパク質の安定化

Info

Publication number
JPH09501418A
JPH09501418A JP7505271A JP50527194A JPH09501418A JP H09501418 A JPH09501418 A JP H09501418A JP 7505271 A JP7505271 A JP 7505271A JP 50527194 A JP50527194 A JP 50527194A JP H09501418 A JPH09501418 A JP H09501418A
Authority
JP
Japan
Prior art keywords
protein
aqueous solution
concentration
peg
polar organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7505271A
Other languages
English (en)
Japanese (ja)
Inventor
力 荒川
ニーブン，ラルフ・ダブリユ
プレストレスキー，ステイーブン・ジエイ
Original Assignee
アムジエン・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アムジエン・インコーポレーテツド filed Critical アムジエン・インコーポレーテツド
Publication of JPH09501418A publication Critical patent/JPH09501418A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Colloid Chemistry (AREA)
JP7505271A 1993-07-19 1994-07-19 エアゾル化タンパク質の安定化 Pending JPH09501418A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9384093A 1993-07-19 1993-07-19
US08/093,840 1993-07-19
PCT/US1994/008136 WO1995003034A1 (fr) 1993-07-19 1994-07-19 Stabilisation de proteines administrees dans un aerosol

Publications (1)

Publication Number Publication Date
JPH09501418A true JPH09501418A (ja) 1997-02-10

Family

ID=22241106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7505271A Pending JPH09501418A (ja) 1993-07-19 1994-07-19 エアゾル化タンパク質の安定化

Country Status (8)

Country Link
EP (1) EP0710102A1 (fr)
JP (1) JPH09501418A (fr)
AU (1) AU691514B2 (fr)
CA (1) CA2167538A1 (fr)
FI (1) FI960253L (fr)
NO (1) NO960217L (fr)
NZ (1) NZ271181A (fr)
WO (1) WO1995003034A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003519175A (ja) * 1999-12-30 2003-06-17 カイロン コーポレイション インターロイキン−２の肺送達のための方法
JP2004532861A (ja) * 2001-05-21 2004-10-28 インジェット　デジタル　エアロソルズ　リミテッド 経肺経路を介するタンパク質送達のための組成物
JP2011506396A (ja) * 2007-12-13 2011-03-03 グラクソ グループ リミテッド 肺送達用組成物

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
DK1129720T3 (da) 2000-02-29 2004-09-27 Pfizer Prod Inc Stabiliseret granulocyt-kolonistimulerende faktor
EP1471871B1 (fr) 2001-02-02 2007-05-02 Ortho-McNeil Pharmaceutical, Inc. Traitement de dysfonctionnements neurologiques au moyen de sulfamates de fructopyranose et d'erythropoietine
US20030072717A1 (en) 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
JP2004087560A (ja) 2002-08-23 2004-03-18 Sansha Electric Mfg Co Ltd 電源装置
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2414560B1 (fr) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Procédé de revêtement d'une surface d'un composant
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
PE20130036A1 (es) 2009-11-25 2013-02-03 Boehringer Ingelheim Int Nebulizador
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
CN103717239B (zh) 2011-08-02 2017-08-01 希格马托制药工业公司 适合于吸入的氧化抗生物素蛋白的药物组合物
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
EP3030298B1 (fr) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nébuliseur
EP2835146B1 (fr) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Atomiseur
AP2016009486A0 (en) 2014-05-07 2016-10-31 Boehringer Ingelheim Int Nebulizer, indicator device and container
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
WO2015169732A1 (fr) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Contenant, nébuliseur et utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003519175A (ja) * 1999-12-30 2003-06-17 カイロン コーポレイション インターロイキン−２の肺送達のための方法
JP2004532861A (ja) * 2001-05-21 2004-10-28 インジェット　デジタル　エアロソルズ　リミテッド 経肺経路を介するタンパク質送達のための組成物
JP2011042695A (ja) * 2001-05-21 2011-03-03 Injet Digital Aerosols Ltd 経肺経路を介するタンパク質送達のための組成物
JP2011506396A (ja) * 2007-12-13 2011-03-03 グラクソ グループ リミテッド 肺送達用組成物

Also Published As

Publication number Publication date
NZ271181A (en) 1998-06-26
NO960217D0 (no) 1996-01-18
AU7473294A (en) 1995-02-20
FI960253A7 (fi) 1996-03-18
FI960253A0 (fi) 1996-01-18
NO960217L (no) 1996-03-18
EP0710102A1 (fr) 1996-05-08
AU691514B2 (en) 1998-05-21
CA2167538A1 (fr) 1995-02-02
FI960253L (fi) 1996-03-18
WO1995003034A1 (fr) 1995-02-02

Similar Documents

Publication Publication Date Title
JPH09501418A (ja) エアゾル化タンパク質の安定化
JP2656944B2 (ja) タンパク質性治療剤のエアロゾール化
ES2274651T3 (es) Formulacion farmaceutica en forma de aerosol para aparte bucal y pulmonar y dispensador de dosis medidas que contiene la misma.
US6503481B1 (en) Compositions for aerosolization and inhalation
EP1731140B1 (fr) Formulation d'aerosol medicinal
JPH08504756A (ja) 副甲状腺ホルモンの活性フラグメントの肺導入
WO2002043695A3 (fr) Suspensions stables, susceptibles de se presenter en aerosol et composees de proteines dans de l'ethanol
CA2353959A1 (fr) Formulation d'aerosol medicamenteuse
JP2774379B2 (ja) 医薬エアロゾール組成物ならびにそれらのウイルス疾患の治療および予防用途
JP2003520829A (ja) 医薬エアゾール製剤
US20120042886A1 (en) Method of producing a nicotine medicament and a medicament made by the method
EP1250127A1 (fr) Procede d'administration d'une formulation aerosol medicale
JP2003528701A (ja) 定量吐出装置および液体配合物
JP2002527473A (ja) フォルモテロールを含む貯蔵可能な活性物質濃縮物
US20220184080A1 (en) Nebulized imatinib formulations, manufacture, and uses thereof
KR100316358B1 (ko) 클로로플루오로카본 비함유 모메타손 푸로에이트 에어로졸 제형
Onoue et al. Bioactive analogues and drug delivery systems of vasoactive intestinal peptide (VIP) for the treatment of asthma/COPD
JP2000514085A (ja) 医薬シクロスポリンａエーロゾル溶液処方物
AU2002367032B8 (en) Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
JP2001518923A (ja) 鼻腔用メラトニン組成物
US7186402B2 (en) Medicinal aerosol compositions with an amide and/or ester containing excipient compound
MXPA01009466A (es) Preparacion farmaceutica solubilizada en propelente de aerosol.
US20210244805A1 (en) Pharmaceutical for prevention of bleomycin-induced pulmonary fibrosis
WO2002094283A2 (fr) Utilisation de phospholipides dans le traitement de maladie degenerative du poumon et pour ameliorer l'administration de medicaments
AU2008203785A1 (en) Compositions for aerosolization and inhalation